20 articles
A Lancet Healthy Longevity editorial calls for systemic elevation of cancer survivorship care as a public health and longevity priority.
A bespoke DNA vaccine tailored to individual glioblastoma tumors shows promising immunological activity in one of oncology's hardest challenges.
A phase 1 trial of a neoantigen DNA vaccine for glioblastoma found strong immune responses and survival rates exceeding historical benchmarks.
New molecular analysis tool could revolutionize treatment decisions for chronic myelomonocytic leukemia patients.
A comprehensive review in CA Cancer J Clin maps the molecular biology, treatment strategies, and equity gaps in high-grade serous ovarian cancer.
New EUS techniques enable liquid biopsies, AI-assisted diagnosis, and personalized therapy testing for pancreatic and liver diseases.
New research reveals young and elderly cervical cancer patients have completely different molecular signatures requiring age-specific treatments.
Large study reveals cancer survivors have higher biological age than cancer-free individuals, with strongest mortality predictions from epigenetic clocks.
Scientists develop advanced drug delivery methods to detect and eliminate harmful senescent tumor cells that promote cancer spread.
Study identifies blood markers that distinguish long-term survivors from short-term survivors in brain cancer treatment.
Cambridge scientists engineer a nanoprobe that detects therapy-induced senescence non-invasively through a simple urine colorimetric test.
A comprehensive review reveals how combining genomics, proteomics, and metabolomics is uncovering new AML targets and improving patient outcomes.
New targeted therapies and personalized treatments are transforming ovarian cancer care, offering hope for better outcomes and longer survival.
Intratumoral senescent cells shielded by PD-L2 may explain why chemotherapy often falls short — and point to a new combination strategy.
Researchers use advanced cell profiling to develop personalized immune treatments for thyroid cancer patients.
Comprehensive review reveals how artificial intelligence is transforming cancer diagnosis and treatment approaches.
Study of 183 brain tumor samples reveals distinct telomere maintenance patterns that could guide personalized cancer therapy.
New research reveals how tiny cellular packages from aging cells might be engineered to deliver targeted cancer treatments.
A phase 3 trial finds scheduling immunochemotherapy before 3 PM nearly doubles progression-free and overall survival in NSCLC patients.
Researchers respond to peer critique of risk-based, non-invasive hepatocellular carcinoma surveillance in metabolic liver disease patients.
